USE OF A MARKER COMBINATION COMPRISING OSTEOPONTIN AND CARCINOEMBRYONIC ANTIGEN IN THE ASSESSMENT OF COLORECTAL CANCER

摘要

The present invention relates to a method aiding in the assessment ofcolorectal cancer (= CRC). It discloses the use of a marker combinationcomprising osteopontin and carcinoembryonic antigen in the assessment ofcolorectal cancer. Furthermore, it especially relates to a method forassessing colorectal cancer from a liquid sample, derived from an individualby measuring at least the markers osteopontin and carcinoembryonic antigen insaid sample. The marker combination comprising osteopontin andcarcinoembryonic antigen can, e.g., be used in the early detection ofcolorectal cancer or in the surveillance of patients who undergo therapy, e.g.surgery.